[ad_1]
Immunocore Holdings IMCR is set to give its latest quarterly earnings report on Wednesday, 2023-03-01. Here’s what investors need to know before the announcement.
Analysts estimate that Immunocore Holdings will report an earnings per share (EPS) of $0.00.
Immunocore Holdings bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Here’s a look at Immunocore Holdings’s past performance and the resulting price change:
| Quarter | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.80 | |||
| EPS Actual | 0.13 | -0.17 | -0.48 | -1.21 |
| Price Change % | 1.14% | -2.58% | 1.45% | -0.49% |
| Quarter | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.80 | |||
| EPS Actual | 0.13 | -0.17 | -0.48 | -1.21 |
| Price Change % | 1.14% | -2.58% | 1.45% | -0.49% |
Stock Performance
Shares of Immunocore Holdings were trading at $54.21 as of February 27. Over the last 52-week period, shares are up 142.88%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Immunocore Holdings visit their earnings calendar on our site.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.